Neutralizing antibodies against flaviviruses, Babanki virus, and Rift Valley
fever virus in Ugandan bats by Kading, Rebekah C. et al.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
USDA National Wildlife Research Center - Staff 
Publications 
U.S. Department of Agriculture: Animal and 
Plant Health Inspection Service 
2018 
Neutralizing antibodies against flaviviruses, Babanki virus, and 
Rift Valley fever virus in Ugandan bats 
Rebekah C. Kading 
CDC, rebekah.kading@colostate.edu 
Robert M. Kityo 
Makerere University 
Eric C. Mossel 
CDC 
Erin M. Borland 
CDC 
Teddie Nakayiki 
Uganda Virus Research Institute 
See next page for additional authors Follow this and additional works at: https://digitalcommons.unl.edu/icwdm_usdanwrc 
 Part of the Life Sciences Commons 
Kading, Rebekah C.; Kityo, Robert M.; Mossel, Eric C.; Borland, Erin M.; Nakayiki, Teddie; Nalikka, Betty; 
Nyakarahuka, Luke; Ledermann, Jeremy P.; Panella, Nicholas A.; Gilbert, Amy T.; Crabtree, Mary B.; 
Peterhans, Julian Kerbis; Towner, Jonathan S.; Amman, Brian R.; Sealy, Tara K.; Nichol, Stuart T.; Powers, 
Ann M.; Lutwama, Julius J.; and Miller, Barry R., "Neutralizing antibodies against flaviviruses, Babanki 
virus, and Rift Valley fever virus in Ugandan bats" (2018). USDA National Wildlife Research Center - Staff 
Publications. 2090. 
https://digitalcommons.unl.edu/icwdm_usdanwrc/2090 
This Article is brought to you for free and open access by the U.S. Department of Agriculture: Animal and Plant 
Health Inspection Service at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion 
in USDA National Wildlife Research Center - Staff Publications by an authorized administrator of 
DigitalCommons@University of Nebraska - Lincoln. 
Authors 
Rebekah C. Kading, Robert M. Kityo, Eric C. Mossel, Erin M. Borland, Teddie Nakayiki, Betty Nalikka, Luke 
Nyakarahuka, Jeremy P. Ledermann, Nicholas A. Panella, Amy T. Gilbert, Mary B. Crabtree, Julian Kerbis 
Peterhans, Jonathan S. Towner, Brian R. Amman, Tara K. Sealy, Stuart T. Nichol, Ann M. Powers, Julius J. 
Lutwama, and Barry R. Miller 
This article is available at DigitalCommons@University of Nebraska - Lincoln: https://digitalcommons.unl.edu/
icwdm_usdanwrc/2090 
RESEARCH ARTICLE
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ABSTRACT
Introduction: A number of arboviruses have previously been isolated from naturally-infected
East African bats, however the role of bats in arbovirus maintenance is poorly understood.
The aim of this study was to investigate the exposure history of Ugandan bats to a panel of
arboviruses.
Materials and methods: Insectivorous and fruit bats were captured from multiple locations
throughout Uganda during 2009 and 2011–2013. All serum samples were tested for neutra-
lizing antibodies against West Nile virus (WNV), yellow fever virus (YFV), dengue 2 virus
(DENV-2), Zika virus (ZIKV), Babanki virus (BBKV), and Rift Valley fever virus (RVFV) by plaque
reduction neutralization test (PRNT). Sera from up to 626 bats were screened for antibodies
against each virus.
Results and Discussion: Key findings include the presence of neutralizing antibodies against
RVFV in 5/52 (9.6%) of little epauletted fruit bats (Epomophorus labiatus) captured from
Kawuku and 3/54 (5.6%) Egyptian rousette bats from Kasokero cave. Antibodies reactive to
flaviviruses were widespread across bat taxa and sampling locations.
Conclusion: The data presented demonstrate the widespread exposure of bats in Uganda to
arboviruses, and highlight particular virus-bat associations that warrant further investigation.
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Introduction
Uganda has a rich history in arbovirology field and
laboratory studies beginning in the early 1930’s at the
Rockefeller Foundation’s Yellow Fever Research Institute
(currently known as the Uganda Virus Research Institute
(UVRI)). Notably, researchers at the UVRI are credited
with the isolation and discovery of over 20 novel arbo-
viruses from the country including Semliki Forest (SFV),
West Nile (WNV), o’nyong-nyong (ONNV),
Bunyamwera (BUNV), Bwamba (BWAV), and Zika
viruses (ZIKV) [1], as well as the elucidation of the
sylvatic transmission cycles for both yellow fever virus
(YFV) and ZIKV in Uganda [2–4]. Among the virus
ecology studies focused on vertebrate reservoirs, research
at UVRI included investigations on bats for the purposes
of virus discovery [5,6], surveillance [7,8], and evaluation
of pathogenicity and infectivity of potential vertebrate
hosts to arthropods [9]. These valuable studies demon-
strated a widespread seroprevalence of arboviruses
among Ugandan bats [7,8]. However, interpretation of
these serological data is challenging due to the cross-
reactivity of flavivirus antibodies, providing incomplete
field evidence for a potential role of bats in the transmis-
sion cycles of particular arboviruses.
During 2008–2010, the CDC Division of Vector-
borne Diseases (CDC/DVBD) re-initiated arbovirus sur-
veillance activities in collaboration with UVRI [10].
During these investigations, the sources of a number of
blood meals identified from mosquitoes included fruit
bats. These mosquito-bat contacts were documented
from Maramagambo Forest in Queen Elizabeth
National Park, and Semliki Forest in Western Uganda
[11]. Additionally, the particular mosquito species which
had engorged on fruit bats are known to be associated
with a number of medically-important arboviruses:
Coquillettidia (Cq.) fuscopennata (Theobald) (YFV,
Sindbis, chikungunya viruses), Culex (Cx.) perfuscus
Edwards (WNV, Oropouche, Sindbis, Wesselsbron,
Usutu, Babanki viruses), Cx. (Cx.) neavei Theobald
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(WNV, Babanki, Spondweni, Sindbis, Koutango viruses),
and Cx. (Cx.) decens group (WNV, chikungunya,
Babanki viruses)[10]. Considering this evidence for expo-
sure of bats to bites from mosquitoes associated with
arboviruses, an investigation to evaluate the seropreva-
lence of Ugandan bats to a panel of arboviruses was
undertaken. The purpose of this study was to follow-up
on earlier field investigations which reported high sero-
prevalence of known arboviruses, particularly flaviviruses
[7,8] in bats. Our goal was to identify bat-virus associa-
tions that would warrant further study for their potential
ecological significance for a role of bats in arbovirus
transmission and maintenance.
Materials and methods
Sample collection
Bats were captured from multiple locations through-
out Uganda during 2011–2013 (Table 1, Figure 1).
Additional samples collected from Egyptian rousette
bats captured previously at Maramagambo Forest in
2009 were provided for inclusion in this serosurvey.
All bat captures were conducted under the approval of
IACUC protocols 1731AMMULX (Maramagambo
samples) and 010–015 (all other samples). Bats were
captured using harp traps or mist nets, and upon cap-
ture, placed individually in holding bags. Blood from
bats captured in Maramagambo forest was collected as
described by Towner et al. [12]. All other bats were
anesthetized with halothane and bled by cardiac punc-
ture, then euthanized by halothane overdose and cervi-
cal dislocation. Blood from bats captured in locations
other than Maramagambo forest was collected directly
into serum separator tubes and centrifuged in the field,
and placed immediately in liquid nitrogen dry shippers.
Serological testing
All serum samples were frozen at −80°C until they
were tested for neutralizing antibodies against flavi-
viruses (Flaviviridae: Flavivirus): WNV, YFV, Dengue
virus type 2 (DENV-2), ZIKV; Babanki virus (BBKV)
(Togaviridae: Alphavirus), and Rift Valley fever virus
(RVFV) (Phenuiviridae: Phlebovirus) by plaque
Table 1. Species and sampling locations for bat sera tested, Uganda 2009, and 2011–2013.
Species Common name Location Collection date Latitude Longitude
Chaerephon pumilus Little free-tailed bat Zika forest Jun-11 0.11667 32.53333
Banga Nakiwogo Feb-12 0.08333 32.45000
Kisubi Jan-13 0.11826 32.53017
Kawuku Jan-13 0.13487 32.53392
Hipposideros ruber Noack’s leaf-nosed bat Kapkwai cave Feb-12 1.33333 34.41667
Mops condylurus Angolan free-tailed bat Zika forest Jun-11 0.11667 32.53333
Banga, Nakiwogo Jun-11 0.08333 32.45000
Nycteris macrotis Large-eared slit-faced bat Kaptum cave Feb-12 1.33333 34.38333
Eidolon helvum African straw-colored fruit-bat Bugonga Jun-11 0.05000 32.46667
Jinja Feb-12 0.41667 33.20000
Epomophorus labiatus Little epauletted fruit bat Kikaaya Jun-11 0.37017 32.58932
Buwaya Lugonjo Jun-2011, Feb-2012 0.08333 32.43333
Kasange Jun-11 0.15000 32.40000
Kawuku Jan-13 0.13487 32.53392
Lissonycteris angolensis Angolan soft-furred fruit bat Kapkwai cave Feb-12 1.33333 34.41667
Rousettus aegyptiacus Egyptian rousette bat Maramagambo Nov-09 −0.26667 30.05000
Tutum cave Feb-12 1.28333 34.46667
Kasokero cave Jan-13 −0.34214 31.96627
Figure 1. Sampling locations for bats, 2009 – 2013. Capture locations for all bats tested in this study.
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reduction neutralization test (PRNT) [13]. While all
four dengue serotypes circulate in Africa, we chose to
screen samples for DENV-2 due to the frequent invol-
vement of this serotype in epidemics in Africa [14].
Twofold serial dilutions of serum were incubated with
100 plaque-forming units (PFU) of WNV (strain
UG2274, Uganda), DENV-2 (strain DakHD10674,
Senegal), YFV (strain BA-55, Nigeria), ZIKV
(MP766, Uganda), BBKV (46A-186), and RVFV
(MP-12). A cutoff of ≥80% reduction in PFU on
Vero cells was selected. For flaviviruses, bats with an
antibody titer (PRNT80) at least four-fold higher than
the other flaviviruses were considered positive for anti-
body to that virus. Due to the serologic cross-reactivity
observed among the flaviviruses, bats with neutralizing
antibody titers against multiple flaviviruses for which
no fourfold difference in titer was observed or with
weak titers PRNT80 ≤ 20, where no four-fold differ-
ence could be observed, were considered flavivirus
antibody positive with no specific virus identified.
For some samples which returned ambiguous flavi-
virus results, we attempted to detect residual flavivirus
RNA from tissue samples collected from those bats in
order to positively identify the infecting virus. For
these samples, RNA from liver/spleen homogenates
was screened using pan-flavivirus primers [15]. For
BBKV and RVFV, serum samples with a titer of
PRNT80 ≥ 20 were considered seropositive. Because
of limited serum volumes, not enough serum was
available to test all bats for every virus, so some sam-
ples were not tested on the entire panel.
Results
This study reports the results of serological testing
conducted on 626 bats captured in Uganda: 323 bats
captured from 2011 to 2013, and an additional 303
samples from Egyptian rousette bats sampled during
2009. Neutralizing antibodies against flaviviruses
were common. Significant neutralizing antibody titers
against WNV were found in 2/8 (25%) African straw-
colored fruit bats sampled in Jinja in 2012, as well as
in 2/25 (8%) little epauletted fruit bats sampled in
Kikaaya and 1/19 (5.3%) from Buwaya Lugonjo
(Tables 2 and 3). One of 45 (2.2%) Egyptian rousette
bats sampled from Tutum cave had a neutralizing
antibody titer against YFV (Tables 2 and 3). One of
two little free-tailed bats (50%) and 1/2 (50%)
Angolan free-tailed bats sampled from Zika forest in
2011 contained specific antibodies against DENV-2
virus, as well as the single little epauletted fruit bat
from Buwaya Lugonjo that same year (Tables 2 and
3). However, 85/626 (13.5%) of bats possessed neu-
tralizing antibodies against an undetermined flavi-
virus for which a 4-fold difference in antibody titer
was not observed for any one of the flaviviruses
included in the panel (Tables 2 and 3). Among
these bats, all 15/64 of the flavivirus antibody-positive
little free-tailed bats captured from Kawuku in 2013
reacted only to DENV-2, however at titers that were
not distinguishable from other flaviviruses based on
our criteria. Table 3 presents the endpoint antibody
titer of five representative bats for which a specific
Table 2. Prevalence of neutralizing antibodies detected in Ugandan bats, 2009 – 2013. Number positive/number tested for each
virus in each location and year.
Seroprevalence (PRNT80)
Common name N Year Location WNV YFV DENV-2 ZIKAV
Flavivirus
non-
specific BBKV
Alphavirus
non-
specific RVFV
Little free-tailed
bat
2 2011 Zika forest 0/2 0/2 1/2 0/2 0/2 0/2 0/2 0/2
15 2012 Banga Nakiwogo 0/15 0/15 0/15 0/12 5/15 0/14 0/14 0/15
5 2013 Kisubi 0/5 0/5 0/5 0/5 2/5 0/5 0/5 0/5
64 2013 Kawuku 0/64 0/64 0/64 0/64 15/64* 0/64 0/64 0/64
Noack’s leaf-
nosed bat
3 2012 Kapkwai cave 0/3 0/3 0/3 0/3 1/3 0/3 0/3 0/3
Angolan free-
tailed bat
2 2011 Zika forest 0/2 0/2 1/2 ND 0/2 0/2 0/2 0/1
32 2011 Banga, Nakiwogo 0/32 0/31 0/32 ND 1/32 0/32 0/32 0/31
Large-eared Slit-
faced Bat
10 2012 Kaptum cave 0/10 0/10 1/10 0/7 4/10 0/8 0/8 0/7
African Straw-
colored Fruit-
bat
7 2011 Bugonga 0/7 0/7 0/7 ND 0/7 0/7 0/7 0/7
8 2012 Jinja 2/8 0/8 0/8 0/8 1/8 0/8 0/8 0/8
Little Epauletted
Fruit Bat
25 2011 Kikaaya 2/25 0/25 0/25 ND 0/25 1/25 0/25 0/25
1 2011 Buwaya Lugonjo 0/1 0/1 1/1 0/1 0/1 0/1 0/1 0/1
19 2012 Buwaya Lugonjo 1/19 0/19 0/19 0/19 0/19 0/19 0/19 0/19
4 2011 Kasange 0/4 0/4 0/4 ND 1/4 0/4 0/4 0/4
52 2013 Kawuku 0/52 0/52 0/52 0/52 3/52 0/52 0/52 5/52
Angolan soft-
furred fruit bat
9 2012 Kapkwai cave 0/9 0/9 0/9 0/9 0/9 0/9 0/9 0/9
Egyptian rousette 303 2009 Maramagambo 0/303 0/303 0/303 0/8 34/303 0/112 9/303 ND
45 2012 Tutum cave 0/45 1/45 0/45 0/45 13/45 0/45 0/45 0/45
54 2013 Kasokero cave 0/54 0/54 0/54 0/54 5/54 1/54 0/54 3/54
TOTAL 626 5/626 1/625 3/626 0/292 85/626 2/432 9/626 8/318
*All 15 seropositive bats had low antibody reactive to DENV-2.
ND = not done.
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result was determined, and five representative bats
for which serological results were inconclusive based
on our criteria.
A total of 2/432 (0.5%) bats contained specific
neutralizing antibodies against BBKV: one Egyptian
rousette bat and one little epauletted fruit bat (Tables
2 and 3). Nine of the 303 (3%) Egyptian rousette bats
tested from Maramagambo forest exhibited alpha-
virus neutralizing antibodies, but could not be con-
firmed as BBKV (Table 2). Five of 52 (9.6%) little
epauletted fruit bats from Kawuku and 3/54 (5.6%)
Egyptian rousette bats from Kasokero cave contained
specific neutralizing antibodies against RVFV.
Discussion
Overall, exposure of fruit and insectivorous bat spe-
cies to flaviviruses was widespread, although preva-
lence in any one species was often low, suggesting
possible incidental exposure (Table 2). This common
detection of flavivirus antibodies is consistent with
previous studies [6–8]. In particular, 23/86 (27%)
little free-tailed bats, spanning every collection during
the study period, demonstrated neutralizing antibo-
dies against flaviviruses (Table 2). We were unfortu-
nately not able to distinguish among the flavivirus
infections in the majority of cases, despite using the
most specific antibody assay, the PRNT. It is unclear
whether these ambiguous results are the result of an
infection(s) with one or more of the flaviviruses
included in our panel, or with a different flavivirus
altogether. Flaviviruses including Entebbe bat virus
(ENTV)[5,16], Bukalasa bat virus (BBV) and Dakar
bat virus (DBV)[6,8], have been previously isolated
from little free-tailed and Angolan free-tailed bats in
Uganda, leaving open the possibility that some of the
flavivirus antibody-positive bats in this study had
been infected with one of those other viruses. We
did not assess the serological cross-reactivity between
ENTV, BBV, or DBV with the mosquito-borne
viruses in our panel because they are classified in
different antigenic complexes within the family
Flaviviridae and therefore unlikely to cross-react ser-
ologically [17]. Egyptian rousette bats also displayed a
relatively high flavivirus seroprevalence across all col-
lections, with a total of 53/402 (13%) of Egyptian
rousette bats exhibiting flavivirus neutralizing anti-
bodies. Aside from one bat captured at Tutum cave
which was considered to be antibody-positive for
YFV, we did not generate any convincing evidence
indicating which flavivirus was the infecting virus in
any other Egyptian rousette bat sampled. Follow-up
testing of the liver/spleen homogenates from these
seropositive Egyptian rousette bats using pan-flavi-
virus primers [15] did not result in any positive
amplifications (Kading, unpublished data). The tis-
sues from one little free-tailed bat from 2011 which
yielded an isolate of ENTV, were flavivirus RNA-
positive [16]. Development of specific assays targeting
sub-genomic flaviviral RNA (sfRNA), which can be
present in high amounts in infected cells, may be one
approach to deciphering ambiguous serological
results in future investigations [18,19].
Among the alphaviruses, a variant of Sindbis virus,
BBKV, is known to cause fever and arthralgia in
humans and has been isolated from numerous mos-
quito species across Africa, including Cx. (Cx.) decens
group and Cx. (Cx.) perfuscus Edwards [20,21]. In
this study, two bats were seropositive for BBKV:
one little epauletted fruit bat from Kikaaya, and one
Egyptian rousette bat from Kasokero cave.
Mosquitoes collected in Uganda that were documen-
ted to have engorged on fruit bats included Cx. per-
fuscus on straw-colored fruit bats and Egyptian
rousette bats in Semliki Forest, Cx. (Cx.) neavei
Theobald on Egyptian rousette bats in Semliki
Forest and Maramagambo forest, and Cx decens
group mosquitoes on Egyptian rousette bats in
Maramagambo forest [11]. Further, several isolates
of BBKV were obtained from Cx. perfuscus collected
Table 3. Example end-point titers of arbovirus neutralizing antibodies (PRNT80). The top five lines represent bats for which a
specific result was determined; the bottom five lines represent bats for which serological results were inconclusive.
PRNT80 endpoint titer
Bat # Common Name Site Date BBKV WNV
DENV-
2 ZIKAV YFV RVFV Result reported
1 Little epauletted fruit bat Kikaaya 2011 80 <10 <10 ND <10 <10 BBKV positive
96 Little epauletted fruit bat Buwaya
Lugonjo
2011 <10 <10 40 ND <10 <10 DENV-2 positive
210 African straw-colored fruit
bat
Jinja 2012 <10 >320 <10 <10 20 <10 WNV positive
228 Egyptian rousette bat Tutum cave 2012 <10 <10 20 <10 80 <10 YFV positive
472 Egyptian rousette bat Kasokero cave 2013 <20 <20 20 <20 <20 160 RVFV antibody positive; flavivirus non-
specific
98 Little epauletted fruit bat Kasange 2011 <10 20 <10 ND <10 10 flavivirus non-specific; RVFV negative
173 Little free-tailed bat Banga
Nakiwogo
2011 ND <10 20 ND 20 <40 flavivirus non-specific
175 Little free-tailed bat Banga
Nakiwogo
2012 <40 <40 80 <40 80 <40 flavivirus non-specific
236 Egyptian rousette bat Tutum cave 2012 <10 10 10 <10 20 <10 flavivirus non-specific
247 Egyptian rousette bat Tutum cave 2012 <10 <10 10 <10 20 <10 flavivirus non-specific
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from multiple locations in Uganda during this same
sampling period [21]. Among the 40 blood meals
previously identified from Cx. perfuscus in Uganda
[11], 90% were taken from mammalian hosts, and
10% from avian hosts comprising at least 11 different
species [11]. The majority of mammalian blood meals
(26/36; 72%) came from ungulates, however, blood
meals from bats comprised 7.5% of the total blood
meals identified from this mosquito species [11].
Whether bats contribute to the transmission cycle of
BBKV or are merely incidentally exposed through
being fed upon by mosquitoes is unclear.
The involvement of a wild mammal reservoir in
the epidemiologic cycle of RVFV is also unknown.
Olive et al. [22] reviewed what is currently known
about the role of wild mammals in the maintenance
of RVFV. As with many vertebrate taxa, the potential
involvement of bats in the interepidemic mainte-
nance of RVFV has not been thoroughly investigated.
Available experimental data suggest that RVFV is
capable of replication in bats, and that infection
could be asymptomatic [22]. Experimental inocula-
tion of Schreiber’s long-fingered bats (Miniopterus
schreibersii) and Cape serotines (Eptesicus capensis)
confirmed that these bats were capable of becoming
infected with RVFV without showing signs of clinical
illness [22,23]. Further, RVFV has been previously
isolated from several bat species including Peters’
lesser epauletted fruit bat (Micropteropus pusillus),
the Aba leaf-nosed bat (Hipposideros abae) and
Sundevall’s leaf-nosed bat (Hipposideros caffer),
Franquet’s epauletted fruit bat (Epomops franqueti),
and the common butterfly bat (Glauconycteris argen-
tata) [24–26], demonstrating that bats are naturally
exposed to this virus.
RVFV is endemic to Uganda, characterized by low
levels of enzootic activity as opposed to the large-scale
epidemics experienced by neighboring East African
countries [27]. RVFV has been previously isolated
from mosquitoes captured on the Entebbe peninsula
[28], and a localized outbreak in the Kabale district of
Western Uganda in 2016 confirms recent RVFV cir-
culation [29]. In this study, bats from two collections
contained several individuals with neutralizing antibo-
dies against RVFV. These collections comprised 3/54
(5.5%) Egyptian rousette bats from Kasokero cave
captured in 2013, and 5/52 (9.6%) little epauletted
fruit bats from Kawuku, also from 2013. Kasokero
cave and Kawuku are both located on the shore of
Lake Victoria, and are approximately 80 km apart
(Figure 1). In addition to the bats considered seropo-
sitive with an antibody titer of PRNT80 ≥ 20, there
were several additional little epauletted fruit bats from
Kikaaya (2011) and Buwaya Lugonjo (2011–2012), and
one Egyptian rousette bat from Tutum cave (2012)
with antibody titers of PRNT80 = 10 for RVFV that
were considered inconclusive. If these additional
results are indicative of a true infection with RVFV,
these observations collectively suggest that exposure of
fruit bats in Uganda to RVFV is fairly widespread
(Kasokero cave to Tutum cave is >200km). However,
it is also possible that at least some of these results are
attributable to circulation of a different, unidentified,
phlebovirus. Mourya et al. [30] reported a novel bat
phlebovirus named Malsoor virus, related to severe
fever with thrombocytopenia syndrome virus
(SFTSV). Malsoor virus was isolated from a related
fruit bat (Rousettus leschenaultia) in Western India
[30]. Mossel et al. [21] reported two isolations of
Arumowot virus (Phenuiviridae, Phlebovirus) from
Culex mosquitoes collected in Jinja, Uganda, in 2012.
While Malsoor and Arumowot viruses are both dis-
tantly related to RVFV [30], we did not evaluate the
potential for cross-reactivity of these samples to other
phleboviruses. The ability of Egyptian rousette bats
and little epauletted fruit bats to become infected
with RVFV and develop viremias high enough to
infect feeding mosquitoes is unknown.
An important aspect to the ecology of arbovirus
transmission that was not addressed in this study is
the influence of geographic location and land-use/
land cover on the prevalence of arbovirus antibodies
in bats. The bat species captured in this study are all
widely distributed in Uganda, but tend to occupy
particular habitats such as man-made structures,
caves, or tall trees. The agro-ecological conditions
associated with the bat collection locations would
also influence the presence and abundance of mos-
quito vectors through the availability of suitable larval
habitats and preferred hosts. The co-occurrence of
vector, host, and virus with landscape and environ-
mental conditions is important to the emergence and
circulation of arboviruses. Bat migration and disper-
sal patterns also make it difficult to know where they
would have become infected. Future investigations
should include modelling component to evaluate the
co-incidence of vector and host distribution and
pathogen detection data in an ecological context.
In conclusion, this study provides novel data on the
exposure of multiple species of fruit and insectivorous
bats in Uganda to a variety of arboviruses. While the role
of bats in arbovirus transmission cycles is still unfolding,
we have built upon previous studies [6,8,11,21] to
demonstrate ecological associations between bats, arbo-
viruses, and mosquito vectors in Uganda. This study
provides additional field evidence of mosquito-bat con-
tact through the detection of neutralizing antibodies in
bat populations against arboviruses which were contem-
poraneously isolated from mosquitoes in Uganda (i.e.
WNV, BBKV)[21]. To further define and quantify the
contribution of bats to arbovirus transmission cycles,
more data are needed on the contact rates between dif-
ferent species of bats withmosquito vectors, as well as the
competency of these bat species as amplification hosts for
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specific viruses [31]. In particular, experimental studies
are needed to evaluate the ability of Egyptian rousette bats
and little epauletted fruit bats to support replication of
BBKV and RVFV and develop viremias high enough to
infect feeding mosquitoes. These experimental data
would provide important insight into the epidemiological
significance and interpretation of the serological data
presented in this study.
Acknowledgments
We thank the Field Museum Department of Mammology
for donation of voucher material for molecular confirma-
tion of the Rousettus bat species from Tutum cave. Godfrey
Kyazze, David Ssekatawa, and Dennis Ssemwogerere served
as drivers and managed equipment. Bat sampling was
conducted under the permission of the Uganda Wildlife
Authority (TDO/7/92/01), and CDC IACUC approval
numbers (1731AMMULX; CDC/VSPB, Maramagambo
samples)(10-015; CDC/DVBD, all other samples). We also
thank Mr. Tom Okello Obong, Dr. Margret Driciru, and
the Uganda Wildlife Authority rangers at the python cave.
Disclosure statement
No potential conflict of interest was reported by the authors.
Funding
This research was funded through an Interagency
Agreement between the USA Agency for International
Development Emerging Pandemic Threats Program and
the USA Centers for Disease Control and Prevention.
Notes on contributors
Dr. Rebekah C. Kading is currently an Assistant Professor
in the Department of Microbiology, Immunology, and
Pathology, Colorado State University, where her research
program focuses on medical entomology and emerging
arboviruses.
Dr. Robert M. Kityo is a Professor in the College of Natural
Sciences, Makerere University, Kampala Uganda. His
research specializes in small mammals.
Dr. Eric C. Mossel is an arbovirologist with the US Centers
for Disease Control and Prevention, Division of Vector-
borne Diseases in Fort Collins, Colorado. His research
interests include arbovirus surveillance, discovery and diag-
nostic capacity building.
Erin M. Borland is currently a Research Associate in the
Department of Microbiology, Immunology, and Pathology,
Colorado State University, Fort Collins, CO.
Teddy Nakayiki is an Entomology Assistant in the
Arbovirology, Emerging and Re-Emerging Viral
Infections program. She carries out mosquito identification
as well as assists with research on bats.
Betty Nalikka is a research scientist in the College of
Natural Sciences, Makerere University, Kampala, Uganda.
Dr. Luke Nyakarahuka is qualified in Veterinary Medicine
(BVM) and received his Masters in Public Health (MPH)
both from Makerere University, Kampala. His PhD topic at
Norwegian University of Life Sciences was “Epidemiology
of Marburg and Ebola Viruses in Uganda”. Dr.
Nyakarahuka is currently employed as an Epidemiologist
at Uganda Virus Research Institute, Viral Hemorrhagic
Fevers Surveillance Program and Makerere University
College of Veterinary Medicine as a lecturer of
Epidemiology, Zoonoses and Veterinary Public Health.
Jeremy P. Ledermann is a microbiologist for the Centers for
Disease Control and Prevention, Division of Vector-borne
Diseases in Fort Collins, Colorado. He specializes in the
biological interactions between arboviruses and their mos-
quito vector hosts.
Nicholas A. Panella is a biologist with the Centers for
Disease Control in Fort Collins, CO. He has been research-
ing arthropod borne diseases for over 20 years. His
research interests include the ecology of West Nile virus
and integrated pest management.
Dr. Amy Gilbert is a Research Biologist at the National
Wildlife Research Center, which is part of the USDA
APHIS Wildlife Services Program. Her current research
focuses on ecology and spillover of rabies infections in
wildlife, as well as experimental studies regarding the appli-
cation of novel rabies biologics and technologies to
improve vaccination of carnivore wildlife, in efforts to
improve national disease management.
Mary B. Crabtree, currently retired, was an arbovirologist
with the Centers for Disease Control and Prevention,
Division of Vector Borne Diseases.
Dr. Julian Kerbis Peterhans is a professor at Roosevelt
University, Chicago and an Adjunct Curator at the Field
Museum (Chicago). He studies carnivore predation and
small mammal alpha-taxonomy and biogeography in cen-
tral Africa.
Dr. Jonathan S. Towner is a Virologist at the Centers for
Disease Control and Prevention, Viral Special Pathogens
Branch in Atlanta, GA.
Dr. Brian R. Amman received his PhD in Zoology from
Texas Tech University. He is currently employed as a
Disease Ecologist for the Viral Special Pathogens Branch,
Virus Host Ecology Unit, at the Centers for Disease
Control and Prevention in Atlanta, GA. His research inter-
ests include investigating the ecology of, and relationships
between, emerging zoonotic viruses and their reservoirs.
Tara K. Sealy is a microbiologist in the Viral Special
Pathogens Branch Virus Host Ecology team.
Dr. Stuart T. Nichol is the Chief of the Viral Special
Pathogens Branch, Centers for Disease Control and
Prevention in Atlanta, GA.
Dr. Ann M. Powers is the Chief of the Alphavirus lab,
Division of Vector-borne Diseases, Arbovirus Diseases
Branch, Centers for Disease Control and Prevention in
Fort Collins, CO.
6 R. C. KADING ET AL.
Dr. Julius J. Lutwama is head of the Arbovirology,
Emerging and Re-Emerging Viral Infections program,
Uganda Virus Research Institute, Entebbe, Uganda.
Barry R. Miller, currently retired, served as the Chief of the
Virology Activity, CDC Division of Vector-borne Diseases,
Arbovirus Diseases Branch.
ORCID
Luke Nyakarahuka http://orcid.org/0000-0002-2944-
9157
Jonathan S. Towner http://orcid.org/0000-0002-6473-
3049
References
[1] Sempala SDK. Institute profile: the Uganda virus research
institute. Trends in Microbiol. 2002;10:346—348.
[2] Haddow AJ, Smithburn KC, Dick GWA, et al.
Implication of the mosquito Aedes (Stegomyia) africa-
nus Theobald in the forest cycle of yellow fever in
Uganda. Ann Trop Med Parasitol. 1948;42:218—223.
[3] Dick GW, Kitchen SF, Haddow AJ. Zika virus. I.
Isolations and serological specificity. Trans R Soc
Trop Med Hyg. 1952;46:509–520.
[4] Haddow AJ, Williams MC, Woodall JP, et al. Twelve
isolations of Zika virus from Aedes (Stegomyia) afri-
canus (Theobald) taken in and above a Uganda forest.
Bull World Health Organ. 1964;31:57–69.
[5] Lumsden WHR, Williams MC, Mason PJ. A virus
from insectivorous bats in Uganda. Ann Trop Med
Parasitol. 1961;55:389.
[6] Williams MC, Simpson DIH, Shepherd RC, et al.
Virus isolations from bats. East African virus research
institute report, July 1963–December 1964.
Publication of the East African High Commission.
Nairobi, Kenya: Government Printer. 1964; 42.
[7] Shephard RC, Williams MC. Studies on viruses in east
African bats (Chiroptera). 1. Hemagglutination inhi-
bition and circulation of arboviruses. Zoonoses Res.
1964;3:125–139.
[8] Simpson DIH, Williams MC, O’Sullivan JP, et al.
Studies on arboviruses and bats (Chiroptera) in east
Africa II. Isolation and haemagglutination-inhibition
studies on bats collected in Kenya and throughout
Uganda. Ann Trop Med Parasitol. 1968;62:432–440.
[9] Simpson DI, O’Sullivan JP. Studies on arboviruses and
bats (Chiroptera) in east Africa. I. Experimental infec-
tion of bats and virus transmission attempts in Aedes
(Stegomyia) aegypti (Linnaeus). Ann Trop Med
Parasitol. 1968;62:422–431.
[10] Mutebi JP, Crabtree ME, Kading RC, et al. The mos-
quitoes of Western Uganda. J Med Entomol.
2012;49:1289–1306.
[11] Crabtree M, Kading RC, Mutebi J-P, et al. Identification
of host blood from engorged mosquitoes collected in
western Uganda using cytochrome oxidase I gene
sequences. J Wildl Dis. 2013;49:611–626.
[12] Towner JS, Amman BR, Sealy TK, et al. Isolation of
genetically diverse Marburg viruses from Egyptian
fruit bats. PLoS Pathog. 2009;5:e1000536.
[13] Beaty BJ, Calisher CH, Shope RE. Arboviruses. In:
Lennette EH, Lennette DA, Lennette ET, editors.
Diagnostic Procedures for Viral, Rickettsial, and
Chlamydial Infections. 7th ed. Washington DC:
American Public Health Association; 1995. p. 189–212.
[14] Amarasinghe A, Kuritsky JN, William Letson G, et al.
Dengue virus infection in Africa. Emerg Infect Dis.
2011;17:1349–1354.
[15] Kuno G, Chang G-J-J, Tsuchiya KR, et al. Phylogeny
of the genus Flavivirus. J Virol. 1998;72:73–83.
[16] Kading RC, Kityo R, Nakayiki T, et al. Detection of
Entebbe bat virus after 54 years. Am J Trop Med Hyg.
2015;93:475—477.
[17] Calisher CH, Karabatsos N, Dalrymple JM, et al.
Antigenic relationships between flaviviruses as deter-
mined by cross-neutralization tests with polyclonal
antisera. J Gen Virol. 1989;70:37—43.
[18] Hindson CM, Chevillet JR, Briggs HA, et al.
Absolute quantification by droplet digital PCR ver-
sus analog real-time PCR. Nat Methods.
2013;10:1003–1005.
[19] Roby JA, Pijlman GP, Wilusz J, et al. Noncoding
subgenomic flavivirus RNA: multiple functions in
West Nile virus pathogenesis and modulation of host
responses. Viruses. 2014;6:404—427.
[20] Centers for Disease Control and Prevention.
Arbovirus Catalog. [cited 2017 Apr 27]. Available
from: https://wwwn.cdc.gov/arbocat.
[21] Mossel EC, Crabtree MB, Mutebi J-P, et al. Arboviruses
isolated from mosquitoes collected in Uganda,
2008–2012. J Med Entomol. 2017;54:1403—1409.
[22] Olive MM, Goodman SM, Reynes JM. The role of wild
mammals in the maintenance of Rift Valley fever
virus. J Wildl Dis. 2012;48:241—266.
[23] Oelofsen MJ, Van Der Ryst E. Could bats act as
reservoir hosts for Rift Valley fever virus?
Onderstepoort J Vet Res. 1999;66:51—54.
[24] Boiro I, Konstaninov OK, Numerov AD. Isolation of
Rift Valley fever virus from bats in the Republic of
Guinea. Bull Soc Pathol Exot Filiales. 1987;80:62—67.
[25] Butenko AM. Arbovirus circulation in the Republic of
Guinea. Med Parazitol (Mosk). 1996;2:40—45.
[26] Calisher CH, Childs JE, Field HE, et al. Bats: impor-
tant reservoir hosts of emerging viruses. Clin
Microbiol Rev. 2006;19:531–545.
[27] Bird BH, Ksiazek TG, Nichol ST, et al. Rift Valley
fever virus. J Am Vet Med Assoc. 2009;234:883—
893.
[28] Weinbren MP, Williams MC, Haddow AJ.
Isolation of an atypically reacting strain of Rift
Valley fever virus from Lunyo, on the Entebbe
Peninsula. East African Virus Research Institute
Report, July 1955–June 1956. Publication of the
East African High Commission. Nairobi, Kenya:
Government Printer. 1956;21—26.
[29] De St. Maurice A, Nyakarahuka L, Purpura L, et al.
Rift Valley fever response — Kabale District,
Uganda, March 2016. Morb Mortal Wkly Rep.
2016;65:1200–1201.
[30] Mourya DT, Yadav PD, Basu A, et al. Malsoor virus, a
novel bat phlebovirus, is closely related to severe fever
with thrombocytopenia syndrome virus and heartland
virus. J Virol. 2014;88:3605—3609.
[31] Golnar AJ, Turell MJ, LaBeaud AD, et al. Predicting the
Mosquito species and vertebrate species involved in the
theoretical transmission of Rift Valley fever virus in the
USA. PLOS Negl Trop Dis. 2014;8(9):e3163.
INFECTION ECOLOGY & EPIDEMIOLOGY 7
